PRELID1P7

Across TCGA pan-cancer cohorts, PRELID1P7 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated PRELID1P7 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher PRELID1P7 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PRELID1P7 expression acts as an unfavorable survival marker, although some lineages such as UVM and SKCM show a favorable association.

UVM, SKCM, and LUAD are the cancer types where PRELID1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.823	0.465	<.001	85	view →
SKCM	DFS	Tertile	III,IV	0.875	0.554	.001	48	view →
LUAD	OS	Median	II,III,IV	0.600	0.371	.009	48	view →
LIHC	OS	Tertile	III,IV	0.051	0.738	<.001	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	36	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	34	view →
BRCA	DFS	Tertile	III,IV	0.190	0.508	.007	12	view →
UCS	DFS	Tertile	II,III,IV	0.766	0.231	.035	12	view →
LGG	DFS	Tertile	All	0.154	0.428	.005	9	view →
STAD	DFS	Tertile	All	0.575	0.679	.040	6	view →
KICH	OS	Median	All	0.948	0.778	.031	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

PRELID1P7–UVM (DFS)

Open the UVM breakdown →